Skip to main content
Premium Trial:

Request an Annual Quote

Aurora Discovery, Beckman Coulter, ThermoElectron, Tecan, and Genetix Group

Premium

Aurora Discovery last week announced the availability of three new products: the NanoRaptr and BioRaptr FRD liquid handler workstations for non-contact handling of cells, protein solutions, DMSO solutions, and viscous solutions into low-volume microplates; and the ChemLib 1,536- and 3,456-well microplates for low-volume drug discovery, genomics, and proteomics research.


Beckman Coulter has introduced the Biomek FX ADME/Tox Workstation for in vitro drug permeability measurements. The new platform automates the Parallel Artificial Membrane Permeability Analysis method for the determination of passive absorption of a drug candidate through an artificial lipid membrane.


ThermoElectron last week announced the launch of the LeadStream ADME/Tox platform for conducting early-stage drug compound assessments. The platform comprises Orchestrator software for collecting and reporting ADME/Tox data; Reformatter software for online preparation of plates; WorkCell fully automated assay platform; and LC/MS analysis and quantification.


Tecan last week announced the availability of several drug-discovery products, including the Freedom EVO96R multi-channel sample dispensing and microplate processing platform for procedures in genomics, proteomics, sample preparation, compound management, and high-content screening; the LabCD ADME/Tox Evo System, which integrates the LabCD-96 microfluidics disc for a complete ADME/Tox assay platform; the Safire2 monochromator microplate reader for time-resolved fluorescence resonance energy transfer assays based on terbium; and Cellerity, a fully automated high-throughput system for cell and protein production.


Genetix Group has launched the ClonePixFL instrument for mammalian cell imaging and picking. The ClonePixFL adds fluorescent capabilities to Genetix’s existing ClonePix platform.

 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.